Evidence map›Paper›PMID 39831959›Full record

ArticleNeuroradiology2025

Pipeline embolization device for aneurysm recurrence after stent-assisted coiling.

Weiming Kong, Shikai Liang, Xianli Lv

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weiming KongDepartment of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Litang Road 168, Beijing, 102218, China.
Shikai LiangDepartment of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Litang Road 168, Beijing, 102218, China.
Xianli LvDepartment of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Litang Road 168, Beijing, 102218, China. lvxianli000@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSince the emergence of the Pipeline Embolization Device (PED), its off-label use has significantly improved the treatment effectiveness of complex intracranial aneurysms, including the treatment of recurrent aneurysms. Although PED is effective in this situation, there is still a lack of evidence-based medicine for its role in recurrent aneurysms after stent-assisted coiling. The aim of this study is to evaluate the safety and efficacy of PED treatment for recurrent aneurysms after stent-assisted coiling.

methodsThis study included 10 patients who underwent stent-assisted coiling but subsequently received PED treatment again due to aneurysm recurrence or rebleeding. The mean time between initial treatment and subsequent treatment is 12 months. Clinical outcomes include complications and modified Rankin Scale (mRS) scores, as well as evidence of complete occlusion.

resultsAll PEDs were successfully placed, with one case of minor perioperative complications. During the 6-month follow-up after PED implantation, 10 cases of recurrent aneurysms were completely occluded without any adverse clinical sequelae. In one case of vertebral artery aneurysm, balloon dilation was performed before placing PED due to arterial stenosis proximal to the aneurysm.

conclusionThe use of PED to treat recurrent aneurysms after stent-assisted coiling is a safe and effective treatment method.

Indexed as

Embolization, TherapeuticIntracranial AneurysmStentsAdultAgedCerebral AngiographyFemaleHumansMaleMiddle AgedRecurrenceTreatment OutcomeIntracranial aneurysmPipeline embolization deviceRecurrenceStent-assiated coiling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.